Resident of special economic zone (SEZ) Technopolis Moscow will create two research centers (R&D-centers) to develop biological and chemical medicines by the end of 2023. The facilities with a total area of more than five thousand square meters will be opened on the basis of the largest biotechnological production in Russia. Sputnik Technopolis plant received the status of a resident of the capital's SEZ in 2021 and is localized at the Pechatniki site. Today, 650 people work at the enterprise, the area of which reaches 20 thousand square meters. By the end of 2023 the company plans to launch two R&D centers within the production perimeter. They will develop original and import-substituting medical drugs for treatment of socially significant diseases. This will create an additional 120 jobs," said Vladimir Yefimov, Deputy Mayor of Moscow for Economic Policy and Property and Land Relations. In one of the centers the drugs will be developed by chemical synthesis. The second center - the center of biotechnological products development - will create monoclonal antibodies (immune antibodies produced from one plasma cell). The latter will make a pilot site, which will allow reproducing the technologies previously developed by the company for the production of medicines. Then they will be scaled and transferred to the production facilities of the plant and other sites. Residents of SEZ Technopolis Moscow receive a number of tax benefits, as well as federal and city anti-crisis support. The total volume of investments in the plant implementation project at the time of construction exceeded 10 billion rubles, which allowed not only to build the buildings and put them into operation in record time, but also to promptly set up the production of medicines", - said the head of the Department of Investment and Industrial Policy of Moscow Vladislav Ovchinsky. In the development and production of drugs the company is actively cooperating with the leading research centers of the country: the National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, the Moscow State University named after M.V. Lomonosov, National Medical Research Center of Cardiology named after Academician E.I. Chazov Ministry of Health of Russia and many others. As General Director of SEZ Technopolis Moscow Gennady Dyogtev said, about 70 percent of the area of the enterprise, located on the basis of the special economic zone, are clean rooms with laboratories, production areas for research, development and approbation. They are equipped with high-tech equipment, which allows accelerating the development and introduction into production of new products, increasing the availability of innovative and effective drugs for Russian patients. Monoclonal antibodies produced in the biotech center will be used to treat oncological and autoimmune diseases as well as specific infections. According to Timofey Petrov, CEO of the plant, there are not many R&D centers of this level in Russia today that would be integrated into production. The company's partners from the Asia-Pacific region are also involved in the project, and interaction is developing in several areas at once - scientific, technological and educational. SEZ Technopolis Moscow is a territory with a special legal status, which has a preferential regime of entrepreneurial activity for investors. The area of six sites (Pechatniki, Alabushevo, Mikron, MIET, Angstrem, Rudnevo), where high-tech enterprises of SEZ are located, exceeds 260 hectares. About 200 companies have localized their production, 90 of them have the SEZ resident status and enjoy a number of preferences. "For several years Technopolis Moscow has been the leader in international and national industry ratings. ________________________________________ Press service of the SEZ Technopolis Moscow Phone: +7 916 516-15-46 Mail: pr@technomoscow.ru [ mailto:pr@technomoscow.ru ] Subscribe to the SEZ "Technopolis Moscow" in social networks, follow the main news of the SEZ in telegram-channel [ https://t.me/technopolismoscow ] and receive all the most important news delivered to your mail in our weekly newsletter [ http://events.technomoscow.ru/subscribe/?utm_source=site_technomoscow ] .
